Adam Maeder
Stock Analyst at Piper Sandler
(3.99)
# 625
Out of 4,732 analysts
96
Total ratings
52.31%
Success rate
11.51%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Initiates: Neutral | $252 | $239.78 | +5.10% | 1 | Jan 10, 2025 | |
| NARI Inari Medical | Maintains: Neutral | $52 → $80 | $79.55 | +0.57% | 7 | Jan 7, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $12 → $11 | $15.85 | -33.75% | 6 | Nov 13, 2024 | |
| NVRO Nevro | Maintains: Underweight | $7 → $6 | $4.57 | +31.29% | 15 | Nov 12, 2024 | |
| INSP Inspire Medical Systems | Reiterates: Overweight | $255 → $260 | $177.68 | +46.33% | 13 | Nov 5, 2024 | |
| EW Edwards Lifesciences | Maintains: Neutral | $73 → $70 | $69.78 | +0.32% | 12 | Oct 25, 2024 | |
| ISRG Intuitive Surgical | Reiterates: Overweight | $495 → $538 | $592.64 | -9.22% | 17 | Oct 18, 2024 | |
| ABT Abbott Laboratories | Maintains: Overweight | $131 → $133 | $113.48 | +17.20% | 2 | Oct 17, 2024 | |
| NSPR InspireMD | Reiterates: Overweight | $4.5 | $2.72 | +65.18% | 3 | Sep 17, 2024 | |
| M Macy's | Maintains: Hold | $20 → $21 | $13.99 | +50.11% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $2.46 | +225.20% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $10.91 | +83.32% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $30 | $17.40 | +72.41% | 2 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.08 | +140.38% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $7.68 | +134.38% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $48.30 | +104.97% | 3 | May 5, 2022 |
ResMed
Jan 10, 2025
Initiates: Neutral
Price Target: $252
Current: $239.78
Upside: +5.10%
Inari Medical
Jan 7, 2025
Maintains: Neutral
Price Target: $52 → $80
Current: $79.55
Upside: +0.57%
Vicarious Surgical
Nov 13, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $15.85
Upside: -33.75%
Nevro
Nov 12, 2024
Maintains: Underweight
Price Target: $7 → $6
Current: $4.57
Upside: +31.29%
Inspire Medical Systems
Nov 5, 2024
Reiterates: Overweight
Price Target: $255 → $260
Current: $177.68
Upside: +46.33%
Edwards Lifesciences
Oct 25, 2024
Maintains: Neutral
Price Target: $73 → $70
Current: $69.78
Upside: +0.32%
Intuitive Surgical
Oct 18, 2024
Reiterates: Overweight
Price Target: $495 → $538
Current: $592.64
Upside: -9.22%
Abbott Laboratories
Oct 17, 2024
Maintains: Overweight
Price Target: $131 → $133
Current: $113.48
Upside: +17.20%
InspireMD
Sep 17, 2024
Reiterates: Overweight
Price Target: $4.5
Current: $2.72
Upside: +65.18%
Macy's
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $13.99
Upside: +50.11%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $2.46
Upside: +225.20%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $10.91
Upside: +83.32%
May 9, 2023
Maintains: Overweight
Price Target: $25 → $30
Current: $17.40
Upside: +72.41%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.08
Upside: +140.38%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $7.68
Upside: +134.38%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $48.30
Upside: +104.97%